Proteome Sciences PLC
4 July 2002
PRESS RELEASE
4th July, 2002
Completion of Purchase From Aventis R & T
The Board of Proteome Sciences plc is pleased to announce that it has now
completed the acquisition of Xzillion Proteomics GmbH & Co. KG (Xzillion) the
proteomics division of Aventis Research and Technologies GmbH & Co KG (Aventis R
& T). The consideration, which valued Xzillion at £12.6m, was satisfied by the
issue to Aventis R & T of 18 million new ordinary shares of 1p each in the
Company, based on a price of 70p per share. Aventis R & T now owns 15.8% of the
enlarged share capital of Proteome Sciences plc.
- Ends -
For further information please contact:
Proteome Sciences plc
Christopher Pearce, Chief Executive Tel: +44 (0) 1932 865065
E-mail : [email protected]
Public Relations
Ikon Associates
Adrian Shaw Tel: +44 (0)1483 271291 Mobile: +44 (0)797 9900733
E-mail:[email protected]
This information is provided by RNS
The company news service from the London Stock Exchange